13F filer · CIK 1574661
March Altus Capital Management LP
Greenwich, CT · filing since Q4 2013 · last filing Nov 7, 2016
Reported value
$12.9M
+$3.3M vs prior
Positions
8
New / sold out
1 / 2
Added / reduced
3 / 1
Turnover
18.5%
buys $4.6M · sells $2.1M
Top-10 weight
100.0%
Biggest buys vs Q1 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | ACADIA PHARMACEUTICALS INC | +61,171 | +283.8% | +$2.0M |
| New | JNJJOHNSON & JOHNSON | +13,000 | – | +$1.6M |
| Added | ALIGN TECHNOLOGY INC | +11,953 | +222.8% | +$962.8K |
| Added | EDWARDS LIFESCIENCES CORP | +1,168 | +6.7% | +$116.5K |
Biggest sells vs Q1 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | REGENERON PHARMACEUTICALS | -2,291 | -100.0% | $-826.0K |
| Sold out | ATHENAHEALTH INC | -4,900 | -100.0% | $-680.0K |
| Reduced | DEXCOM INC | -7,346 | -38.6% | $-582.7K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2016
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ACADIA PHARMACEUTICALS INCCOM | 82,723 | $2.7M | 20.75% |
| 2 | LLYLILLY ELI & CO | 26,810 | $2.1M | 16.32% |
| 3 | EDWARDS LIFESCIENCES CORPCOM | 18,611 | $1.9M | 14.35% |
| 4 | JNJJOHNSON & JOHNSON | 13,000 | $1.6M | 12.19% |
| 5 | ALIGN TECHNOLOGY INCCOM | 17,319 | $1.4M | 10.78% |
| 6 | ARATANA THERAPEUTICS INCCOM | 218,515 | $1.4M | 10.67% |
| 7 | ALEXION PHARMACEUTICALS INCCOM | 8,599 | $1.0M | 7.76% |
| 8 | DEXCOM INCCOM | 11,700 | $928.0K | 7.17% |